XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
At-the-Market Offering
PREFERRED STOCK
COMMON STOCK
COMMON STOCK
At-the-Market Offering
ADDITIONAL PAID-IN CAPITAL
ADDITIONAL PAID-IN CAPITAL
At-the-Market Offering
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Beginning balance (in shares) at Dec. 31, 2023     15,000            
Beginning balance at Dec. 31, 2023     $ 0            
Beginning balance (in shares) at Dec. 31, 2023       29,130,607          
Beginning balance at Dec. 31, 2023 $ 21,291     $ 3   $ 418,487   $ (397,198) $ (1)
Increase (Decrease) in Shareholders' Equity                  
Net Loss (1,731)             (1,731)  
Reclassification of Realized Gains on Available-for-Sale Investments 0                
Unrealized Gain on Available-for-Sale Investments 25               25
Issuance of common stock, net of offering costs/At-The-Market (in shares)         358,210        
Issuance of common stock, net of offering costs/At-The-Market   $ 560         $ 560    
Vesting of Restricted Stock Units Issued, net of taxes withheld and cancellations (in shares)       67,657          
Issuance of Warrant in connection with the Third Amendment (Note 11) 247         247      
Stock-based Compensation $ 251         251      
Ending balance (in shares) at Mar. 31, 2024     15,000            
Ending balance at Mar. 31, 2024     $ 0            
Ending balance (in shares) at Mar. 31, 2024 29,556,474     29,556,474          
Ending balance at Mar. 31, 2024 $ 20,643     $ 3   419,545   (398,929) 24
Beginning balance (in shares) at Dec. 31, 2024 15,000   15,000            
Beginning balance at Dec. 31, 2024 $ 0   $ 0            
Beginning balance (in shares) at Dec. 31, 2024 34,056,920     34,056,920          
Beginning balance at Dec. 31, 2024 $ 32,586     $ 3   430,207   (397,678) 54
Increase (Decrease) in Shareholders' Equity                  
Net Loss (1,515)             (1,515)  
Reclassification of Realized Gains on Available-for-Sale Investments (56)               (56)
Unrealized Gain on Available-for-Sale Investments 62               62
Issuance of common stock, net of offering costs/At-The-Market (in shares)         0        
Vesting of Restricted Stock Units Issued, net of taxes withheld and cancellations (in shares)       200,983          
Stock-based Compensation $ 445         445      
Ending balance (in shares) at Mar. 31, 2025 15,000   15,000            
Ending balance at Mar. 31, 2025 $ 0   $ 0            
Ending balance (in shares) at Mar. 31, 2025 34,257,903     34,257,903          
Ending balance at Mar. 31, 2025 $ 31,522     $ 3   $ 430,652   $ (399,193) $ 60